There has been a surprising amount of myeloma related news lately; the FDA's approval of panobinostat last week, and now the early release of data apparently showing that Kyprolis helps keep a relapsed patient's myeloma at bay longer than Velcade. My friends at Onyx (now part of Amgen) forwarded me the release announcing the news
I've been accumulating a wide variety of helpful information since the start of the start of the new year. Not enough to post about one by one, but I didn't want that to stop me from passing them along. Onyx (now a division of Amgen) has been working hard to expand FDA approval of Kyprolis.
Reflecting back on last Saturday's Myeloma Beach Party, there are so many lasting memories! Fortunately, party goers captured a lot of them in pictures. Here are a few that I feel best captured the spirit of the event. My favorite part of the party was just as dinner was ending. I walked up and down
After listening to a number of the world's top myeloma experts plead for better, more exacting diagnostics--and more definitive answers as to which patients should be treated with what drugs--news like this should be welcome indeed! The International Myeloma Foundation Announces Partnership With Onyx Pharmaceuticals to Support Black Swan Research Initiative(TM) Black Swan Research Initiative
Big news in the myeloma world last week. Onyx, the company that developed and manufactures the newly FDA approved proteasome inhibitor, Kyprolis (carfilzomib), was purchased by Amgen for a whopping 9.7 billion dollars. If you would like details, I ran a press release about it on our sister site, MyelomaNews.com, October 1st: http://www.myelomanews.com/2013/10/looks-like-proposed-sale-of-onyx-to.html I wrote
Back in August I reported news that the large drug company, Amgen, planned to purchase Onyx Pharmaceuticals. This was big news for multiple myeloma patients; Onyx developed and distributes Kyprolis (carfilzomib), a newly FDA approved proteasome inhibitor. Here are links back to my original posts: BREAKING NEWS: Amgen to buy Onyx Pharmaceuticals Onyx/Amgen sale